Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes.
about
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionAdenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionVasodilators in the treatment of patients with acute myocardial infarction undergoing percutaneous coronary interventionNo reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionShort-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsShort-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trialsA randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised cEfficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-AnalysisTreating and preventing no reflow in the cardiac catheterization laboratory.Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction.Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST-Elevation Myocardial Infarction.Percutaneous coronary intervention and the no-reflow phenomenon.Management of 'no-reflow' complicating reperfusion therapy.The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary interventionPathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiAdenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention.The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention.
P2860
Q24187926-05EAC6F0-9364-4345-A661-FCD8E7B1034AQ24202298-E5FB4C56-CC77-4166-8DB9-03703220D289Q24234883-515BA6C9-17BD-499D-B302-C071AE50D094Q26740252-A3456375-48EC-455E-89D6-68111DE42E45Q26778578-CC46DA8C-37E6-41F0-9D08-8F9411155006Q27013629-1D27914F-B998-447B-8C7F-50E877ED526EQ33642159-11A9DA94-5193-45FC-8531-A1736A53F8D6Q34305843-B17B0CF6-1023-409F-A318-C5136F298792Q36195096-67A290D5-F3CD-41CF-B9E5-60D17026F274Q36302125-4294579D-8815-4808-9F2A-7A3D31A08D3BQ36345768-F9A26B97-27CB-444C-B32D-BA828DDDEFE3Q36366231-EEA37577-EE7E-4364-81D8-CC050BDCE990Q36867295-8935EEB4-5D98-455B-9B2E-0FE95D88CDDEQ37152013-0F12802F-2FFD-4DA4-9468-CFC5384E713EQ37431525-63E568B1-800B-40AC-BB88-5CF65077AEC9Q37774078-584269F8-D960-455E-A53C-82938A9C314CQ37953885-5336C8D2-34AC-4343-BF9F-2E6C0665F788Q38543451-F7568456-8639-484A-91F4-30731AA1838EQ41982365-4E56A7AC-E4B2-4561-9019-048272AB00E0Q42830474-25A7D4F6-47CE-4259-A722-5C957143B733Q55278653-55E0DF82-0E80-4DDF-9BE3-676F41ACDEBF
P2860
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prospective, randomised, contr ...... with acute coronary syndromes.
@ast
Prospective, randomised, contr ...... with acute coronary syndromes.
@en
type
label
Prospective, randomised, contr ...... with acute coronary syndromes.
@ast
Prospective, randomised, contr ...... with acute coronary syndromes.
@en
prefLabel
Prospective, randomised, contr ...... with acute coronary syndromes.
@ast
Prospective, randomised, contr ...... with acute coronary syndromes.
@en
P2093
P2860
P356
P1433
P1476
Prospective, randomised, contr ...... with acute coronary syndromes.
@en
P2093
B Kunadian
K Vijayalakshmi
M A de Belder
R A Wright
V J Whittaker
P2860
P304
P356
10.1136/HRT.2005.075077
P407
P577
2006-01-31T00:00:00Z